Management of Elevated PTH Levels

Initial Diagnostic Evaluation

The American College of Physicians recommends checking serum calcium, phosphorus, 25-OH vitamin D, and kidney function to identify the underlying cause of PTH elevation 1
A comprehensive review of medications that may affect calcium metabolism and contribute to secondary hyperparathyroidism is necessary 1
Evaluation for chronic kidney disease is crucial as PTH levels begin to rise early in the course of CKD, often before significant changes in calcium or phosphorus 1

The American Academy of Clinical Endocrinologists recommends supplementing with cholecalciferol or ergocalciferol to achieve 25-OH vitamin D levels ≥30 ng/mL if deficiency is present 1
Target vitamin D levels of >20 ng/ml (50 mmol/l) at minimum, as recommended by the Endocrine Society 2
For CKD patients, consider dietary phosphate restriction and phosphate binders if hyperphosphatemia is present, as suggested by the National Kidney Foundation 1
A bone biopsy can be useful for more accurate assessment in CKD patients with PTH between 100-500 pg/mL who develop unexplained hypercalcemia, bone pain, or increased bone alkaline phosphatase, according to the American Journal of Kidney Diseases 3

Parathyroidectomy is indicated for persistent serum levels of intact PTH >800 pg/mL associated with hypercalcemia and/or hyperphosphatemia refractory to medical therapy, as recommended by the American College of Surgeons 1
Before considering parathyroid ablation therapy, patients with PTH levels less than 800-1,000 pg/mL may require bone biopsy to document increased bone formation rate and histological findings of hyperparathyroidism, according to the American Journal of Kidney Diseases 3
Effective surgical options include subtotal parathyroidectomy or total parathyroidectomy with parathyroid tissue autotransplantation, as suggested by the American College of Surgeons 1, 2

Low-dose active vitamin D could be helpful as a supplement to nutritional vitamin D and dietary phosphate restriction for controlling PTH in CKD patients not on dialysis, according to Kidney International 4

Check serum calcium and phosphorus monthly for the first 3 months, then every 3 months, as recommended by the American College of Physicians 1
Measure PTH levels every 3 months for 6 months, then every 3-6 months thereafter, according to the Endocrine Society 1
For patients who undergo parathyroidectomy, monitor ionized calcium every 4-6 hours for the first 48-72 hours after surgery, then twice daily until stable, as suggested by the American College of Surgeons 1, 2

PTH levels between 100-500 pg/mL in CKD patients have insufficient sensitivity and specificity to reliably predict bone disease, according to the American Journal of Kidney Diseases 3
Do not delay surgical intervention in patients with recurrent renal stones and hyperparathyroidism, as this can lead to progressive renal damage, as recommended by the American Urological Association 2